{"data":{"id":"us-in/ic-16-42-25-3","jurisdiction":"us-in","citation":"IC 16-42-25-3","heading":"\"Interchangeable\"","body":"Sec. 3. As used in this chapter, \"interchangeable\" means:\n(1) a determination by the federal Food and Drug Administration that a biosimilar product may be substituted for a reference biological product without the intervention of the health care provider that prescribed the biological product; or\n(2) concerning a biological product filed under 21 U.S.C. 355(b)(2), a product that is designated as therapeutically equivalent by the federal Food and Drug Administration in the Approved Drug Products with Therapeutic Equivalence Evaluations.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 25. Drugs: Biosimilar Biological Products"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-25-3","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"21370d7c5883891eb7deb34428aae4800eed1faf193b25bb4bb367c1f7a9e06c","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-25-2","next":"us-in/ic-16-42-25-4"},"notice":"GroundRules: Original legal text. Not legal advice."}